New blood analyzer feature aims to catch sample damage
NCT ID NCT07345091
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new hemolysis detection feature on the ABL90 FLEX PLUS HEM blood gas analyzer. Hemolysis (damage to red blood cells) can skew test results. Researchers will collect blood samples from 95 adults and check if the device correctly flags damaged samples. The goal is to improve the reliability of blood test results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ABL90 FLEX PLUS HEM device (blood gas analyzer with hemolysis detection feature)
- What this could lead to
- If successful, this could make blood test results more reliable by automatically flagging damaged samples.
- What could go wrong
- This is a small feasibility study (95 participants) testing a device feature, not a treatment. It may not prove the feature works in all real-world settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Bispebjerg Hospital
RECRUITINGCopenhagen, NV, 2400, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.